Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Language Processing | 11 | 2022 | 1166 | 1.500 |
Why?
|
| Electronic Health Records | 17 | 2022 | 4813 | 1.120 |
Why?
|
| Data Mining | 5 | 2021 | 552 | 0.710 |
Why?
|
| Semantics | 1 | 2022 | 612 | 0.600 |
Why?
|
| International Classification of Diseases | 6 | 2020 | 913 | 0.500 |
Why?
|
| Vocabulary, Controlled | 1 | 2016 | 167 | 0.480 |
Why?
|
| Arthralgia | 1 | 2018 | 461 | 0.460 |
Why?
|
| Information Storage and Retrieval | 1 | 2019 | 818 | 0.450 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 510 | 0.440 |
Why?
|
| Algorithms | 14 | 2022 | 14023 | 0.430 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4340 | 0.280 |
Why?
|
| Radiology | 2 | 2016 | 2114 | 0.240 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 2423 | 0.220 |
Why?
|
| Phenotype | 7 | 2022 | 16572 | 0.190 |
Why?
|
| Biomedical Research | 1 | 2016 | 3429 | 0.170 |
Why?
|
| Chondrocalcinosis | 1 | 2021 | 84 | 0.170 |
Why?
|
| Pattern Recognition, Automated | 2 | 2016 | 993 | 0.170 |
Why?
|
| Spondylarthritis | 1 | 2020 | 61 | 0.160 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2020 | 155 | 0.160 |
Why?
|
| Vital Signs | 1 | 2019 | 144 | 0.150 |
Why?
|
| Pulmonary Embolism | 3 | 2016 | 2571 | 0.150 |
Why?
|
| Area Under Curve | 5 | 2021 | 1636 | 0.150 |
Why?
|
| Pulmonary Artery | 2 | 2016 | 1927 | 0.140 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2018 | 224 | 0.140 |
Why?
|
| Creatinine | 1 | 2019 | 1897 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 931 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2016 | 1223 | 0.110 |
Why?
|
| Aortic Aneurysm | 1 | 2018 | 648 | 0.110 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 14676 | 0.110 |
Why?
|
| Registries | 2 | 2021 | 8236 | 0.110 |
Why?
|
| Software | 3 | 2016 | 4433 | 0.100 |
Why?
|
| Models, Anatomic | 1 | 2015 | 684 | 0.100 |
Why?
|
| Uncertainty | 1 | 2015 | 752 | 0.090 |
Why?
|
| Angiography | 1 | 2015 | 1597 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 15915 | 0.080 |
Why?
|
| Suicidal Ideation | 1 | 2018 | 1447 | 0.080 |
Why?
|
| Prognosis | 4 | 2021 | 29672 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 1585 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 2157 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 3222 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2019 | 5520 | 0.060 |
Why?
|
| Humans | 23 | 2022 | 761098 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 4189 | 0.060 |
Why?
|
| Observer Variation | 3 | 2016 | 2611 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2020 | 3754 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2020 | 3801 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 2948 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2016 | 3812 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2014 | 3111 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2014 | 4506 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 3582 | 0.050 |
Why?
|
| Unified Medical Language System | 1 | 2019 | 89 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2018 | 80673 | 0.040 |
Why?
|
| Current Procedural Terminology | 1 | 2018 | 89 | 0.040 |
Why?
|
| Female | 11 | 2021 | 392458 | 0.040 |
Why?
|
| Male | 10 | 2021 | 360675 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 585 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39121 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13382 | 0.030 |
Why?
|
| Linear Models | 2 | 2018 | 5869 | 0.030 |
Why?
|
| Resins, Synthetic | 1 | 2015 | 25 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15308 | 0.030 |
Why?
|
| Middle Aged | 9 | 2021 | 220835 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 20600 | 0.030 |
Why?
|
| Acute Disease | 2 | 2016 | 7240 | 0.030 |
Why?
|
| Audiovisual Aids | 1 | 2015 | 99 | 0.030 |
Why?
|
| Rheology | 1 | 2015 | 347 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 6504 | 0.030 |
Why?
|
| Software Validation | 1 | 2014 | 59 | 0.030 |
Why?
|
| Automation, Laboratory | 1 | 2014 | 102 | 0.030 |
Why?
|
| Iopamidol | 1 | 2014 | 186 | 0.030 |
Why?
|
| Adult | 5 | 2021 | 221083 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 20120 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15513 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2019 | 2706 | 0.030 |
Why?
|
| Aged | 6 | 2021 | 169266 | 0.020 |
Why?
|
| Workflow | 1 | 2016 | 850 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2016 | 877 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2253 | 0.020 |
Why?
|
| Survivors | 1 | 2021 | 2369 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1650 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3419 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 2691 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2015 | 2115 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10083 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8456 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9324 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 41486 | 0.020 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2015 | 1004 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 2515 | 0.020 |
Why?
|
| Peptides | 1 | 2018 | 4353 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2015 | 1865 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 14607 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 58946 | 0.010 |
Why?
|
| Veterans | 1 | 2018 | 2652 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9648 | 0.010 |
Why?
|
| Disease Progression | 1 | 2021 | 13506 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 7969 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2014 | 5249 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13254 | 0.010 |
Why?
|
| Contrast Media | 1 | 2014 | 5311 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10514 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12670 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15717 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 29872 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2016 | 24013 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 39953 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 74219 | 0.010 |
Why?
|
| United States | 1 | 2017 | 72337 | 0.010 |
Why?
|
| Child | 1 | 2017 | 80134 | 0.000 |
Why?
|
Concepts
(110)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_